Haploidentical Hematopoietic Stem Cell Transplantation With Anti‐Thymocyte Globulin in the Treatment of Older Adults With Hematological Malignancy
Our study suggests that haplo-SCT with ATG is a safe and effective treatment option for patients aged ≥ 60 years. <b>Trial Registration</b>: The authors have confirmed clinical trial registration is not needed for this submission.
Authors
- Baoquan Song (ORCID: https://orcid.org/0000-0002-6046-8209)
- Aining Sun (ORCID: https://orcid.org/0000-0002-6355-9595)
- Qi Zhou (ORCID: https://orcid.org/0000-0003-4567-6525)
- Shengli XUE
- Xiaowen Tang
- Depei Wu
- Mingming Hu
- Miao Miao
- Jian J. Zhang
- Jingjing Han
- Yue Han
- Ying Wang
- Yin Liu
- Jun Chen
- Suning Chen
- Feng Chen
- Xin Kong
Institutions
- Nanchang University (CN)
- Soochow University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Suzhou Guangji Hospital (CN)
- Suzhou Traditional Chinese Medicine Hospital (CN)
- First Affiliated Hospital of Soochow University (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- eJHaem
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1002/jha2.70242
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Soochow University